About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 372 record(s)
Req # A-2022-05127
Copies of all emails to/from Douglas Clark, Melanie Bourassa-Forcier, Tanya Potashnik and Health Canada officials from November 1, 2021 to January 31, 2022.Organization: Patented Medicine Prices Review Board Canada
March 2022
Nothing to report this month
Organization: Women and Gender Equality Canada
Req # A-2020-18439
Copies of all email exchanges between the PMPRB and pCPA and CADTH members in the provincial offices from June 1, 2019 to November 19, 2020.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2021-10646
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Boehringer Ingelheim over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2021-10666
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Sanofi Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2021-00023
Please provide copies of the documents with the following internal document: Correspondence MCU2018-00666Organization: Women and Gender Equality Canada
February 2022
Req # A-2021-00053
Please provide a final electronic copy of the organizations, projection descriptions and total amounts that was provided as part of the 6.2 million funding to the Assembly of First Nations as announced by Minister Monsef on August 6, 2021.” https://www.canada.ca/en/women-gender-equality/news/2021/08/tbc---department-for-women-and-gender-equality-canada---gender-based-violence-program0.htmlOrganization: Women and Gender Equality Canada
February 2022
Req # A-2021-00054
I am seeking applications for grants and funds from the Centre Boréal in New Brunswick sent by the former director of this organization, Angèle Losier, to Women and Gender Equality Canada. Relevant period: 2016-03-31 to 2020-03-31. Purpose of application: verify the salary of the branch as indicated in applications for grants and funds.Organization: Women and Gender Equality Canada
February 2022
Req # A-2021-10762
Provide all emails, preparation documents, and similar materials that Douglas Clark and other PMPRB executives sent or received related to the recent statement given to the Hill Times for their May 25th article. Include, but do not limit the scope of the request to, emails related to the drafting of the statement.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-10767
Copies of all briefing material provided to Douglas Clark from May 22, 2021 to June 11, 2021.Organization: Patented Medicine Prices Review Board Canada
January 2022